Periodic Reporting for period 1 - STI-001 (Turn Cancer Immunotherapy Effective in Most Patients)

Stimunity is a spin-off of the French foundation for cancer research, Institute Curie, exploiting a cutting-edge new cancer immunotherapy. The company was created in 2016 by Dr Nicolas Manel (scientific leader) and Sylvain Carlioz (business leader), based on more than 10-years...